Amendment

Amendment. Shall have the same meaning as that set forth in the Agreement unless defined otherwise herein

Amendment. To Warrant. The title and first paragraph of the Warrant is amended and restated as follows: Void after 5:30 P.M. New York City time on January 24, 2010 SERIES C COMMON STOCK PURCHASE WARRANT of PHARMA-BIO SERV, INC. This is to certify that, FOR VALUE RECEIVED, [_____________], or registered assigns ("Holder"), is entitled to purchase, on the terms and subject to the provisions of this Warrant, from Pharma-Bio Serv, Inc., a Delaware corporation (the "Company"), at an exercise price (the... "Exercise Price") of seventy three and 44/100 cents ($.7344) per share, __________ (_____) shares of common stock, par value $.0001 per share ("Common Stock"), of the Company at any time during the period (the "Exercise Period") commencing on the date of this Warrant and ending at 5:30 P.M. New York City time, on January 24, 2010; provided, however, that if such date is a day on which banking institutions in the State of New York are authorized by law to close, then on the next succeeding day which such banks are not authorized to close. The number of shares of Common Stock to be issued upon the exercise or conversion of this Warrant and the price to be paid for a share of Common Stock may be adjusted from time to time in the manner set forth in this Warrant. The shares of Common Stock deliverable upon such exercise or conversion, and as adjusted from time to time, are hereinafter sometimes referred to as "Warrant Shares," and the exercise price for the purchase of a share of Common Stock pursuant to this Warrant in effect at any time, as the same may be adjusted from time to time, is hereinafter sometimes referred to as the "Exercise Price." This Warrant was issued pursuant to a subscription agreement (the "Subscription Agreement") between the Company and the initial holder of this Warrant. View More

Amendment. This Amendment to the Alnylam Co-Exclusive License Agreement

Amendment. The Amendment to Stockholders' Agreement substantially in the form of Exhibit A hereto.

Amendment. As an inducement to the Investor to enter into the Amendment, the Corporation (i) has authorized the issuance of 2,500,000 shares of Series A-1 Convertible Preferred Stock, par value $0.001 per shares (the 'Series A-1 Preferred Shares') and 1,000,000 shares of Series A-2 Convertible Preferred Stock, par value $0.001 per share, of the Corporation (the 'Series A-2 Preferred Shares'); (ii) has issued to the Investor 100,000 Series A-2 Preferred Shares and (iii) has agreed to enter into this... Agreement in order to grant certain registration rights to the Investor with respect to the shares of Common Stock issuable upon conversion of the Series A-1 Preferred Shares and the Series A-2 Preferred Shares. View More

Amendment. This Amendment shall be binding upon, and shall inure to the benefit of, the parties hereto and their respective successors and assigns.

Amendment. Shall be a "Loan Document" for all purposes of the Amended Credit Agreement and the other Loan Documents.

Amendment. The Amendment to the Partnership Agreement, substantially in the form attached as Exhibit A hereto

Amendment. Shall have the meanings given to them in the Loan Agreement

Amendment. To Section 1.01 [Defined Terms]. The definition of the term "Senior Financial Officer" contained in Section 1.01 of the Agreement is amended to read as follows: "Senior Financial Officer" means the chief financial officer, principal accounting officer, treasurer, assistant treasurer, or controller of the Borrower; provided that any executive vice president, the treasurer, any assistant treasurer, or the corporate controller of Borrower is authorized by Borrower to execute and deliver any... Borrowing Request. View More